Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Resveratrol and Paclitaxel

supplement:

Resveratrol

Research Papers that Mention the Interaction

Paclitaxel induced the levels of both DNA damages in the sperms, but resveratrol ameliorated this effect.
Theriogenology  •  2019  |  View Paper
It was reported recently that resveratrol could sensitise a number of cancer cell lines to the anticancer actions of several other cancer drugs, including paclitaxel.
These observations suggest that the strategy of concomitant use of resveratrol with paclitaxel is detrimental in certain types of human cancers.
European journal of cancer  •  2010  |  View Paper
Nine phenolic antioxidants ((+)-catechin, (-)-epicatechin, fisetin, gallic acid, morin, myricetin, naringenin, quercetin and resveratrol ) were tested for inhibition of paclitaxel metabolism.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2003  |  View Paper
Here, the possibility that resveratrol (Res), an anticancer plant polyphenol, could increase the susceptibility of breast cancer cells to paclitaxel (Pacl) by affecting E2/ERα/NGB pathway has been evaluated.
Journal of cellular physiology  •  2019  |  View Paper
RES , dose-dependently, suppresses the expression of survivin, a molecular biomarker of cancer and a member of the inhibitor of apoptosis (IAP) family and its co-administration with PTX inhibits the effect of this drug on cell viability.
These data show that RES increases the sensitivity of PTX resistant renal cells to drug treatment.
This dramatically counteracts the effects of RES on cell survival in the presence of PTX.
Frontiers in bioscience  •  2019  |  View Paper
Importantly, RES augmented the effects of paclitaxel in both cell lines.
Anticancer research  •  2014  |  View Paper
Taken together, our results indicate that resveratrol may have the potential to negate the therapeutic efficacy of taxol and suggest that consumption of resveratrol-related products may be contraindicated during cancer therapy with taxol.
This pronounced antagonistic function of resveratrol against taxol was associated with changes in multiple signal transduction pathways, but not with tubulin polymerization.
Unexpectedly, resveratrol effectively prevented tumor cell death induced by taxol in 5637 bladder cancer cells.
Molecular nutrition & food research  •  2010  |  View Paper
After being treated with resveratrol at different concentrations separately, the expressions of HIF-1alpha, mdr1 and MRP1 in CNE2 cells decreased significantly as compared with paclitaxel alone or paclitaxel plus verapamil (P<0.01).
Combined with paclitaxel , 25, 50, 100 and 200 micromol/L of resveratrol increased the apoptotic rate of CNE2 cells from (22.14+/-1.09)% to (23.24+/-1.37)%, (27.57+/-2.01)%, and (30.36+/-2.31)%, respectively.
Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine  •  2009  |  View Paper
Although simultaneous exposure to resveratrol plus paclitaxel did not result in significant synergy, resveratrol (10 microM, 3 days) significantly enhanced the subsequent antiproliferative effect of paclitaxel.
Resveratrol (10 microM, 3 days) similarly enhanced the subsequent apoptotic effects of paclitaxel.
These results suggest that resveratrol may be a promising alternative therapy for lung cancer and that lung cancer cells exposed to resveratrol have a lowered threshold for killing by paclitaxel.
Anticancer research  •  2003  |  View Paper
Administration of RES combined with PAC prevented, while PAC induced, neutropenia and lymphocytosis, and increased the percentage of ANAE-positive lymphocytes.
Biotechnic & histochemistry : official publication of the Biological Stain Commission  •  2019  |  View Paper
Show More